ADORA2A: Adenosine receptor A2a
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Receptor for adenosine.
- Drugs that act on it: 19
- With a US drug page: 1
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Istradefylline | Approved | Adenosine A2a receptor antagonist | Antagonist | — |
| AMP579 | — | Adenosine A2a receptor agonist | Agonist | — |
| Apadenoson | — | Adenosine A2a receptor agonist | Agonist | — |
| Binodenoson | — | Adenosine A2a receptor agonist | Agonist | — |
| BVT.115959 | — | Adenosine A2a receptor agonist | Agonist | — |
| Ciforadenant | — | Adenosine A2a receptor antagonist | Antagonist | — |
| Etrumadenant | — | Adenosine A2a receptor antagonist | Antagonist | — |
| Evodenoson | — | Adenosine A2a receptor agonist | Agonist | — |
| Imaradenant | — | Adenosine A2a receptor antagonist | Antagonist | — |
| PBF-509 | — | Adenosine A2a receptor antagonist | Antagonist | — |
| PBF-999 | — | Adenosine A2a receptor antagonist | Antagonist | — |
| Preladenant | — | Adenosine A2a receptor antagonist | Antagonist | — |
| Regadenoson anhydrous | — | Adenosine A2a receptor agonist | Agonist | — |
| Sipagladenant | — | Adenosine A2a receptor inverse agonist | Inverse agonist | — |
| Sonedenoson | — | Adenosine A2a receptor agonist | Agonist | — |
| ST1535 | — | Adenosine A2a receptor antagonist | Antagonist | — |
| Tozadenant | — | Adenosine A2a receptor antagonist | Antagonist | — |
| UK432097 | — | Adenosine A2a receptor agonist | Agonist | — |
| Vipadenant | — | Adenosine A2a receptor antagonist | Antagonist | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associationsGenes and Related Targets
Complexes and families that share a gene with this target- Genes
- ADORA2A
Drugs and mechanisms are from ChEMBL CHEMBL251 (CC BY-SA 3.0). Gene name, function (UniProt P29274, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets